RBM：2024减疟伙伴关系孕期疟疾工作组：关于以社区为基础的孕期疟疾间歇预防性治疗的共识声明报告（法语版）

Although IPTp has been recommended by WHO for nearly two decades, with a target of 80% coverage, in 2022, among eligible pregnant women, 64% received IPTp1, 54% received IPTp2, and only 42% received IPTp3, despite the fact that 78% of pregnant women used ANC services at least once during their pregnancy.2 The ongoing gap between high ANC attendance in sub-Saharan Africa and the low proportion of eligible pregnant women receiving the recommended at least three doses of IPTp is a critical misse